Literature DB >> 23452826

Lack of correlation between opioid dose adjustment and pain score change in a group of chronic pain patients.

Lucy Chen1, Trang Vo, Lindsey Seefeld, Charlene Malarick, Mary Houghton, Shihab Ahmed, Yi Zhang, Abigail Cohen, Cynthia Retamozo, Kristen St Hilaire, Vivian Zhang, Jianren Mao.   

Abstract

UNLABELLED: Despite the increasing use of opioid analgesics for chronic pain management, it is unclear whether opioid dose escalation leads to better pain relief during chronic opioid therapy. In this study, we retrospectively analyzed clinical data collected from the Massachusetts General Hospital Center for Pain Medicine over a 7-year period. We examined 1) the impact of opioid dose adjustment (increase or decrease) on clinical pain score; 2) gender and age differences in response to opioid therapy; and 3) the influence of clinical pain conditions on the opioid analgesic efficacy. A total of 109 subjects met the criteria for data collection. We found that neither opioid dose increase, nor decrease, correlated with point changes in clinical pain score in a subset of chronic pain patients over a prolonged course of opioid therapy (an average of 704 days). This lack of correlation was consistent regardless of the type of chronic pain including neuropathic, nociceptive, or mixed pain conditions. Neither gender nor age differences showed a significant influence on the clinical response to opioid therapy in these subjects. These results suggest that dose adjustment during opioid therapy may not necessarily alter long-term clinical pain score in a group of chronic pain patients and that individualized opioid therapy based on the clinical effectiveness should be considered to optimize the treatment outcome. PERSPECTIVE: The study reports a relationship, or lack thereof, between opioid dose change and clinical pain score in a group of chronic pain patients. The study also calls for further investigation into the effectiveness of opioid therapy in the management of chronic nonmalignant pain conditions.
Copyright © 2013 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23452826      PMCID: PMC3662976          DOI: 10.1016/j.jpain.2012.12.012

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  29 in total

Review 1.  Opioid therapy for chronic pain.

Authors:  Jane C Ballantyne; Jianren Mao
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

2.  Age-dependent intrathecal opioid escalation in chronic noncancer pain patients.

Authors:  Salim M Hayek; I Elias Veizi; Samer N Narouze; Nagy Mekhail
Journal:  Pain Med       Date:  2011-08-02       Impact factor: 3.750

3.  An intravenous ketamine test as a predictive response tool in opioid-exposed patients with persistent pain.

Authors:  Steven P Cohen; Shuxing Wang; Lucy Chen; Connie Kurihara; Geselle McKnight; Matthew Marcuson; Jianren Mao
Journal:  J Pain Symptom Manage       Date:  2008-09-11       Impact factor: 3.612

4.  Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base.

Authors:  C Richard Chapman; David L Lipschitz; Martin S Angst; Roger Chou; Richard C Denisco; Gary W Donaldson; Perry G Fine; Kathleen M Foley; Rollin M Gallagher; Aaron M Gilson; J David Haddox; Susan D Horn; Charles E Inturrisi; Susan S Jick; Arthur G Lipman; John D Loeser; Meredith Noble; Linda Porter; Michael C Rowbotham; Karen M Schoelles; Dennis C Turk; Ernest Volinn; Michael R Von Korff; Lynn R Webster; Constance M Weisner
Journal:  J Pain       Date:  2010-04-28       Impact factor: 5.820

5.  Opioid use, misuse, and abuse in patients labeled as fibromyalgia.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; Ann Gamsa; Mark A Ware; Yoram Shir
Journal:  Am J Med       Date:  2011-10       Impact factor: 4.965

Review 6.  Opioids in chronic non-cancer pain: systematic review of efficacy and safety.

Authors:  Eija Kalso; Jayne E Edwards; Andrew R Moore; Henry J McQuay
Journal:  Pain       Date:  2004-12       Impact factor: 6.961

7.  Altered quantitative sensory testing outcome in subjects with opioid therapy.

Authors:  Lucy Chen; Charlene Malarick; Lindsey Seefeld; Shuxing Wang; Mary Houghton; Jianren Mao
Journal:  Pain       Date:  2009-02-23       Impact factor: 6.961

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

9.  Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study.

Authors:  Robert N Jamison; Carol L Link; Lisa D Marceau
Journal:  Pain Med       Date:  2009-08-07       Impact factor: 3.750

10.  Opioid rotation with extended-release opioids: where should we begin?

Authors:  Srinivas Nalamachu
Journal:  Int J Gen Med       Date:  2011-12-30
View more
  14 in total

1.  Chronic Opioid Use Following Surgery for Oral Cavity Cancer.

Authors:  John Pang; Kathryn R Tringale; Viridiana J Tapia; William J Moss; Megan E May; Timothy Furnish; Linda Barnachea; Kevin T Brumund; Assuntina G Sacco; Robert A Weisman; Quyen T Nguyen; Jeffrey P Harris; Charles S Coffey; Joseph A Califano
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

Review 2.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

3.  Distribution of naloxone for overdose prevention to chronic pain patients.

Authors:  Marion A Coe; Sharon L Walsh
Journal:  Prev Med       Date:  2015-05-27       Impact factor: 4.018

Review 4.  Pharmacological options for pain control in patients with vertebral fragility fractures.

Authors:  Nuttan Kantilal Tanna; Terence Ong
Journal:  Osteoporos Sarcopenia       Date:  2022-10-03

5.  Opioid use after fracture surgery correlates with pain intensity and satisfaction with pain relief.

Authors:  Arjan G J Bot; Stijn Bekkers; Paul M Arnstein; R Malcolm Smith; David Ring
Journal:  Clin Orthop Relat Res       Date:  2014-04-29       Impact factor: 4.176

6.  Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study.

Authors:  Corey J Hayes; Erin E Krebs; Teresa Hudson; Joshua Brown; Chenghui Li; Bradley C Martin
Journal:  Addiction       Date:  2020-01-15       Impact factor: 6.526

7.  Design considerations for a remote randomized multi-site clinical trial evaluating an e-health self-management program for chronic pain patients receiving opioid therapy.

Authors:  Theresa Winhusen; Marian Wilson; Rowena J Dolor; Jeff Theobald; Daniel Lewis; Saundra L Regan; Mary Beth Vonder Meulen
Journal:  Contemp Clin Trials       Date:  2020-12-10       Impact factor: 2.226

8.  New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation.

Authors:  Joanne Salas; Jeffrey F Scherrer; Frank David Schneider; Mark D Sullivan; Kathleen K Bucholz; Thomas Burroughs; Laurel A Copeland; Brian K Ahmedani; Patrick J Lustman
Journal:  Pain       Date:  2017-02       Impact factor: 7.926

9.  Opioids contribute to fracture risk: a meta-analysis of 8 cohort studies.

Authors:  Zhaowei Teng; Yun Zhu; Feihu Wu; Yanhong Zhu; Xiguang Zhang; Chuanlin Zhang; Shuangneng Wang; Lei Zhang
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

10.  Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat.

Authors:  Scott J Thompson; Mark H Pitcher; Laura S Stone; Farid Tarum; Gang Niu; Xiaoyuan Chen; Dale O Kiesewetter; Petra Schweinhardt; M Catherine Bushnell
Journal:  Pain       Date:  2018-09       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.